You just read:

Frost & Sullivan Applauds argenx for Enhancing the Therapeutic Qualities of Human Antibodies with its Proprietary Antibody Discovery Platform, SIMPLE Antibody™

News provided by

Frost & Sullivan

05 Oct, 2016, 07:00 BST